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Masaya Yamamoto, PhD,c Yoshiaki Saji, MD,a Takeshi Nishina, MD, PhD,a and Yasuhiko Tabata, PhD,
DMSc, DPharm,c Kyoto and Aichi, JapanIn spite of advances in the treatment of ischemic heart dis-
ease, there exist patients who are not eligible for current
revascularization procedures because of diffuse coronary
lesions or too-small vessel caliber. To offer a more effective
therapeutic option for these patients, we developed biologic
coronary artery bypass grafting (Bio-CABG), which uses
sustained release of basic fibroblast growth factor (bFGF)
and an omental flap as a connector between the right gastro-
epiploic artery (RGEA) and ungraftable coronary arteries.1,2
Here we report the first clinical case of Bio-CABG.
CLINICAL SUMMARY
Weusedgelatin hydrogel sheets as a sustained release carrier
for bFGF.3 bFGF and the gelatin hydrogel sheet were prepared
as previously described.4 An aqueous solution of bFGF (250
mg/3 mL) was applied to freeze-dried gelatin hydrogel sheets
(15 3 10 cm) and then left at an ambient temperature for 1
hour to incorporate bFGF into each gelatin hydrogel sheet.
The sheet slowly released bFGF for approximately 3 weeks.
Bio-CABGwas performed as follows. Through an upper–
median laparotomy, the stomach and omentum were ex-
posed, and arterial branches from the RGEA to the stomach
were ligated and severed from the pylorus along the greater
curvature of the stomach to the end of the RGEA. Arterial
branches from the RGEA to the omentum were left intact.
The diaphragm just below the left ventricular (LV) inferior
wall was opened, and the omentum, including the RGEA,
was passed through this opening into the pericardial sac.
The bFGF-incorporated gelatin hydrogel sheet was cut
into several pieces so that each sheet was appropriately ap-
plied onto the ischemic area of the heart. Subsequently,
the omental flap was attached to the ischemic LV area
with interrupted sutures of 6-0 Prolene (Ethicon, Inc, Somer-
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omental flap. These procedures were easily completed with-
out cardiopulmonary bypass. The Ethics Committee of
Kyoto University approved the study protocol (protocol
no. 650). We obtained written informed consent from the
patients.
The first patient was a 57-year-old man with an old myo-
cardial infarction. Coronary angiographic analysis demon-
strated occlusion of the right coronary artery, stenosis of the
left anterior descending coronary artery, and long segments
of stenoses in the 2 distal left circumflex arteries. Although
dipyridamole Thallium-21 single-photon emission computed
tomographic analysis indicated moderate-to-severe hypoper-
fusion with partial-delay fill-in in the anterior and lateral infe-
rior walls of the LV (Figure 1, A), there were no graftable
coronary arteries in the lateral and inferior LV walls. Thus
we performed off-pump CABG (left internal thoracic artery
to left anterior descending coronary artery) concomitantly
with Bio-CABG in the lateral to inferior wall of the LV.
Six-month postoperative angiography of the RGEA revealed
opacification of the native obtusemarginal branch (Figure 2).
Dipyridamole Thallium-21 single-photon emission com-
puted tomographic analysis indicated recovery of blood per-
fusion in the lateral and inferior walls of the LV in addition to
the anterior LV wall (Figure 1, B). Magnetic resonance im-
ages showed improvement in wall motion, wall thickness,
and systolic thickening in the lateral to inferior LVwall (Fig-
ure 1, C–F). The serum level of bFGF was within the normal
range (ie, unchanged) during the whole study period.
DISCUSSION
Several experimental and clinical studies have reported
promising results with therapeutic angiogenesis as an alter-
native to conventional medical or surgical interventions.
However, they showed myocardial ‘‘staining’’ at best, and
none of them showed opacification of the coronary arteries;
arterial opacification is important because coronary flow
reserve can increase not only through capillaries but also
through arteries/arterioles. To the best of our knowledge,
this is the first clinical report that shows macroscopic opaci-
fication of coronary branches by means of therapeutic angio-
genesis. In the foregoing methods of angiogenesis, the
quality of donor coronary arteries often limits the efficacy
of angiogenesis because they are often diseased or stenosed.ardiovascular Surgery c Volume 138, Number 3 775
Brief Technique ReportsFIGURE 1. Preoperative and postoperative radiologic examinations (short-axis view). A and B, Thallium single-photon emission tomography at stress. C to
F, End-diastolic and end-systolic images of cine magnetic resonance scans. Blood perfusion at stress in the lateral to inferior left ventricular wall improved
after surgical intervention (A and B). Myocardial wall thickness and systolic wall thickening (E and F, black arrows) improved in the lateral to inferior left
ventricular wall after surgical intervention. Preop, Before the operation (A, C, and D); Postop, after the operation (B, E, and F).White arrows, Omental flap.In contrast, here the RGEA, which supplies blood perfusion
to the omental flap, can play an important role as an indepen-
dent, unobstructed, and extracardiac blood source to provide
additional collateral flow (shear stress) for enhancing arte-
riogenic activity in the chronically ischemic region.1,2
FIGURE 2. Postoperative angiography from the right gastroepiploic ar-
tery. The native obtuse marginal branch was clearly opacified from the right
gastroepiploic artery. There exists a communicative vessel (angiogenesis)
between the right gastroepiploic artery and the obtuse marginal branch.
RGEA, Right gastroepiploic artery; OM, obtuse marginal branch.776 The Journal of Thoracic and Cardiovascular SuIn the present study we demonstrated the therapeutic
effects of the Bio-CABG. It was noteworthy that the native
coronary artery was opacified from the extracardiac blood
source, which indicates that Bio-CABG connected the gas-
troepiploic artery to the coronary arteries without surgical
anastomoses and provided additional perfusion from the
RGEA to the ischemic LV wall and improved regional LV
wall motion. We had shown the opacification of coronary
branches by the gastroepiploic artery in animal models,1,2
but here we confirmed it for the first time in a human patient.
Omentum is known to be rich in many angiogenic growth
factors, including vascular endothelial growth factor, chemo-
tactic factors, and progenitor cells.5 In addition, bFGF has
synergistic/additional effects with other angiogenic agents,
such as vascular endothelial growth factor, hepatocyte
growth factor, or platelet-derived growth factor BB.4 Thus
Bio-CABG might be a promising strategy to achieve more
sufficient therapeutic angiogenesis.
In conclusion, we report the first clinical case of bioanas-
tomoses, as shown by the opacification of coronary arteries
by RGEAwithout surgical anastomosis by Bio-CABG. Bio-
CABG might be an alternative therapeutic method of angio-
genesis in patients with severe coronary artery disease who
have no other options. Further study is warranted.
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The association of an aortopulmonary window (APW) and
an anomalous origin of a coronary artery is an exceptional
condition with pathophysiologic specificities that make its
preoperative diagnosis difficult. We report 2 new cases of
APW with anomalous origin of either the right coronary ar-
tery (RCA) or the left coronary artery (LCA) and discuss sur-
gical options for their repair.
CLINICAL SUMMARY
A 8-year-old girl (17 kg) was admitted for an APW
revealed by a systolic murmur. Electrocardiogram showed
a sinus rhythm and no ischemic sign. The chest radiograph
demonstrated increased pulmonary vascularization, and the
cardiothoracic ratio was 0.7. The echocardiography demon-
strated a left ventricular dilatation, low-grade mitral and aor-
tic regurgitations, a large APW, and a severe pulmonary
hypertension. The origin of the LCA was identified in a nor-
mal position, but the origin of the RCA was not seen. Under
normothermic cardiopulmonary bypass, after a vertical aor-
totomy, the left ostium was seen in the left sinus and the right
ostium was located on the pulmonary side of the APW. The
pulmonary trunk was transected, and the RCA was excised
with a large button of pulmonary artery wall. This defect
was repaired with an autologous pericardial patch. The
RCA was reimplanted in the right aortic sinus, and the
APW was closed with a polytetrafluoroethylene patch (Fig-
ure 1). The postoperative course was uneventful, without
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ischemia on the electrocardiogram or on echocardiography.
At 2 years, follow-up, the patient has a normal ventricular
function with New York Heart Association class I.
A 7-month-old boy (7 kg) was admitted for an APW diag-
nosed on a systolic murmur and a mild dyspnea. Electrocar-
diogram showed no ischemic sign. On chest radiograph, the
cardiothoracic ratio was 0.6 and an increased pulmonary vas-
cularization was noted. Echocardiography demonstrated
a left ventricular dilatation and a large APWwith isosystemic
pulmonary hypertension. No anomaly of coronary arteries
was identified. Under normothermic cardiopulmonary by-
pass, a vertical aortotomy was performed and the LCA
ostiumwas seen on the posteriorwall of the pulmonary trunk.
The repair consisted in a tunnel made of the equine pericar-
dial patch used to close the APW, leaving the LCA ostium
on the aortic side of this patch. A small polytetrafluoroethy-
lene patch was used to close the aortotomy. The postopera-
tive course was uneventful. The echocardiography
performed the day after surgery revealed a left ventricular
dysfunction and grade I mitral regurgitation. Both were
regressive on echocardiography at discharge, 9 days after
surgery. A postoperative computed tomography scan was
performed to assess the tunnel patency (Figure 2). At 4
months follow-up, the patient is asymptomatic.
DISCUSSION
The association of an APW and anomalous origin of
a coronary artery is an exceptional condition. It was first de-
scribed by Stopfkuchen and colleagues1 for the RCA, by
Bourlon and colleagues2 for the LCA, and by Chopra and
colleagues3 for the circumflex artery. To date, 11 RCAs, 2
LCAs, and 2 circumflex anomalous coronary arteries with
APW have been reported in the literature.
Diagnosis is difficult with the lack of myocardial ischemic
symptoms because of the peculiar pathophysiology encoun-
tered in this association: The abnormal coronary vessel
originating from the pulmonary artery is perfused by a well-
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